RN
Insider
Robert Nelsen
DirectorRobert Nelsen (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in PRME. Across 1 priced purchase filing, the average 21-session return was -7.7% from execution and -7.7% from disclosure (delay-adjusted; derived). The largest single filing was $10.0M of PRME (3,030,300 sh × $3.30, as filed), executed Aug 1 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-7.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-7.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.0M
shares × price, as filed
Last traded
Aug 1 2025
Filed Aug 1 2025
Volume by month
Buys $10.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
PRME
PRME
PRME · 1 buy · 0 sells
1 filing
Recent filings
PRMEPURCHASE
Prime Medicine, Inc.
View filing →
$10.0M3,030,300 sh × $3.30
Exec Aug 1 2025
Filed Aug 1 2025 · 7:19 PM ET